Literature DB >> 18849863

Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.

Russell W Hinerman1, Daniel J Indelicato, Robert J Amdur, Christopher G Morris, John W Werning, Mikhail Vaysberg, Jessica Kirwan, William M Mendenhall.   

Abstract

INTRODUCTION: Metastatic spread to parotid-area lymph nodes (PALN) occurs in 1% to 3% of patients with cutaneous squamous cell carcinoma of the head and neck. Presented herein is the University of Florida experience using radiation therapy (RT) to treat patients with PALN metastases from a skin primary. METHODS AND MATERIALS: From November 1969 to February 2005, 121 parotids in 117 patients received irradiation for nonmelanotic skin carcinoma metastatic to PALN. Patients were staged by the O'Brien staging system. Of the 121 parotids receiving RT, 17 (14%) were treated preoperatively, 87 (72%) postoperatively, and 17 with RT alone.
RESULTS: Five-year actuarial probabilities of local (parotid) control, local-regional control, disease-free survival and overall survival were 78%, 74%, 70%, and 54%, respectively. When patients were separated by O'Brien P-stage, statistically significant differences were seen among the groups for local (parotid) control, local-regional control, and disease-free survival. A statistically significant decrease in local control was seen in patients treated with positive surgical margins (92% vs. 76%) and in local-regional control for patients treated with preoperative RT or RT alone when compared with postoperative RT (59% and 47% vs. 83%, respectively). The 5-year actuarial probability of freedom from distant metastases was 92%. Three (2.6%) patients suffered severe complications.
CONCLUSIONS: PALN metastases from a cutaneous head and neck primary site are best treated with surgery and postoperative RT. Our data support the hypothesis that the O'Brien staging system is superior to the American Joint Committee on Cancer system for the staging of cutaneous metastases to PALN. Positive surgical margins confer a worse prognosis in terms of local-regional control and disease-free survival. Patients treated with preoperative RT seem to have a worse prognosis than those treated postoperatively, likely a result of patient selection and the surgeon's inability to accurately assess viable tumor extent after preoperative RT. Severe complications are uncommon after surgery and RT for PALN metastases.

Entities:  

Mesh:

Year:  2008        PMID: 18849863     DOI: 10.1097/MLG.0b013e318180642b

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  16 in total

Review 1.  Metastases to the head and neck: an overview.

Authors:  Leon Barnes
Journal:  Head Neck Pathol       Date:  2009-07-05

2.  [Not Available].

Authors:  Bruna Melhoranse Gouveia; Maria Helena de Magalhães Barbosa; Leonardo Hoehl Carneiro; Luzia Abrao El Hadj; Nurimar Conceição Fernandes
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

3.  Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.

Authors:  Wai Keat Wong; Randall P Morton
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-14       Impact factor: 2.503

Review 4.  Parotidectomy for Parotid Cancer.

Authors:  Jennifer R Cracchiolo; Ashok R Shaha
Journal:  Otolaryngol Clin North Am       Date:  2016-02-17       Impact factor: 3.346

5.  Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients.

Authors:  Luluel Khan; Michael Tjong; Hamid Raziee; Justin Lee; Darby Erler; Lee Chin; Ian Poon
Journal:  Support Care Cancer       Date:  2014-10-09       Impact factor: 3.603

Review 6.  High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Clinical Review.

Authors:  Flora Yan; Brittny N Tillman; Rajiv I Nijhawan; Divya Srivastava; David J Sher; Vladimir Avkshtol; Jade Homsi; Justin A Bishop; Erin M Wynings; Rebecca Lee; Larry L Myers; Andrew T Day
Journal:  Ann Surg Oncol       Date:  2021-06-30       Impact factor: 5.344

7.  Elective neck management for squamous cell carcinoma metastatic to the parotid area lymph nodes.

Authors:  Michael P Herman; Robert J Amdur; John W Werning; Peter Dziegielewski; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-05       Impact factor: 2.503

8.  Deep lobe parotidectomy-why, when, and how?

Authors:  Kerry D Olsen; Miquel Quer; Remco de Bree; Vincent Vander Poorten; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-12       Impact factor: 2.503

9.  Cutaneous squamous cell carcinoma of the head and neck.

Authors:  Vivek V Gurudutt; Eric M Genden
Journal:  J Skin Cancer       Date:  2011-02-21

10.  Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid.

Authors:  Fawaz M Makki; Adrian I Mendez; S Mark Taylor; Jonathan Trites; Martin Bullock; Gordon Flowerdew; Robert D Hart
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.